Terms: = Kidney tumors AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Treatment
16 results:
1. Octamer-binding transcription factor 4-positive circulating tumor cell predicts worse treatment response and survival in advanced cholangiocarcinoma patients who receive immune checkpoint inhibitors treatment.
Pei F; Tao Z; Lu Q; Fang T; Peng S
World J Surg Oncol; 2024 Apr; 22(1):110. PubMed ID: 38664770
[TBL] [Abstract] [Full Text] [Related]
2. HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis.
Di Agostino S; Canu V; Donzelli S; Pulito C; Sacconi A; Ganci F; Valenti F; Goeman F; Scalera S; Rollo F; Bagnato A; Diodoro MG; Vizza E; Carosi M; Rufini B; Federici O; Giofrè M; Carboni F; Muti P; Ciliberto G; Strano S; Valle M; Blandino G
Cell Death Dis; 2023 Aug; 14(8):535. PubMed ID: 37598177
[TBL] [Abstract] [Full Text] [Related]
3. Selective HIF2A Inhibitors in the Management of Clear Cell Renal Cancer and Von Hippel-Lindau-Disease-Associated tumors.
Suárez C; Vieito M; Valdivia A; González M; Carles J
Med Sci (Basel); 2023 Jun; 11(3):. PubMed ID: 37489462
[TBL] [Abstract] [Full Text] [Related]
4. Targeting DRD2 by the antipsychotic drug, penfluridol, retards growth of renal cell carcinoma via inducing stemness inhibition and autophagy-mediated apoptosis.
Tung MC; Lin YW; Lee WJ; Wen YC; Liu YC; Chen JQ; Hsiao M; Yang YC; Chien MH
Cell Death Dis; 2022 Apr; 13(4):400. PubMed ID: 35461314
[TBL] [Abstract] [Full Text] [Related]
5. Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro.
Choi HS; Ko YS; Jin H; Kang KM; Ha IB; Jeong H; Song HN; Kim HJ; Jeong BK
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500557
[TBL] [Abstract] [Full Text] [Related]
6. Expression of Components of the Renin-Angiotensin System by Cancer Stem Cells in Renal Clear Cell Carcinoma.
Siljee S; Milne B; Brasch HD; Bockett N; Patel J; Davis PF; Kennedy-Smith A; Itinteang T; Tan ST
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33916968
[TBL] [Abstract] [Full Text] [Related]
7. Aggressive myoepithelial carcinoma with EWSR1-pou5f1 fusion highly responsive to Ewing sarcoma combination chemotherapy.
Shenoy N
Cancer; 2020 Dec; 126(24):5198-5201. PubMed ID: 33048366
[TBL] [Abstract] [Full Text] [Related]
8. Metastatic renal cell carcinoma cells growing in 3D on poly‑D‑lysine or laminin present a stem‑like phenotype and drug resistance.
Brodaczewska KK; Bielecka ZF; Maliszewska-Olejniczak K; Szczylik C; Porta C; Bartnik E; Czarnecka AM
Oncol Rep; 2019 Nov; 42(5):1878-1892. PubMed ID: 31545459
[TBL] [Abstract] [Full Text] [Related]
9. Suppressive effects of iron chelation in clear cell renal cell carcinoma and their dependency on VHL inactivation.
Greene CJ; Sharma NJ; Fiorica PN; Forrester E; Smith GJ; Gross KW; Kauffman EC
Free Radic Biol Med; 2019 Mar; 133():295-309. PubMed ID: 30553971
[TBL] [Abstract] [Full Text] [Related]
10. Galectin-3 promotes CXCR2 to augment the stem-like property of renal cell carcinoma.
Huang CS; Tang SJ; Lee MH; Chang Wang CC; Sun GH; Sun KH
J Cell Mol Med; 2018 Dec; 22(12):5909-5918. PubMed ID: 30246456
[TBL] [Abstract] [Full Text] [Related]
11. Renal Cell Carcinoma, Unclassified with Medullary Phenotype and Synchronous Renal Clear Cell Carcinoma Present in a Patient with No Sickle Cell Trait/Disease: Diagnostic and Therapeutic Challenges.
Lai JZ; Lai HH; Cao D
Anticancer Res; 2018 Jun; 38(6):3757-3761. PubMed ID: 29848739
[TBL] [Abstract] [Full Text] [Related]
12. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
[TBL] [Abstract] [Full Text] [Related]
13. The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylation.
Du Z; Li L; Huang X; Jin J; Huang S; Zhang Q; Tao Q
Oncotarget; 2016 Apr; 7(16):21618-30. PubMed ID: 26943038
[TBL] [Abstract] [Full Text] [Related]
14. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
Wang L; Park P; La Marca F; Than KD; Lin CY
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
[TBL] [Abstract] [Full Text] [Related]
15. treatment of agarose-agarose RENCA macrobeads with docetaxel selects for oct4(+) cells with tumor-initiating capability.
Gazda LS; Martis PC; Laramore MA; Bautista MA; Dudley A; Vinerean HV; Smith BH
Cancer Biol Ther; 2013 Dec; 14(12):1147-57. PubMed ID: 24025409
[TBL] [Abstract] [Full Text] [Related]
16. Establishing a germ cell origin for metastatic tumors using oct4 immunohistochemistry.
Cheng L
Cancer; 2004 Nov; 101(9):2006-10. PubMed ID: 15386301
[TBL] [Abstract] [Full Text] [Related]
